Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: A Danish nationwide cohort study

Br J Dermatol. 2024 Feb 2:ljae042. doi: 10.1093/bjd/ljae042. Online ahead of print.NO ABSTRACTPMID:38305415 | DOI:10.1093/bjd/ljae042

Source: The British Journal of Dermatology - February 2, 2024 Category: Dermatology Authors: Hans Christian Ring Jonathan Thorsen Brian Kirby John R Ingram Nana Aviaaja Lippert Rosen ø Nikolaj Holgersen Valdemar W Nielsen David Nikolai Thein Aagaard Julia-Tatjana Maul Jashin J Wu Jacob P Thyssen Alexander Egeberg Simon F Thomsen Source Type: research